Cytokinetics, Inc
Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors to treat diseases characterized by impaired muscle function. With over 25 years of scientific expertise, the company aims to improve the lives of patients with debilitating muscle diseases through innovative medicines and a robust pipeline of therapies. Their mission is to be a leading muscle biology biopharmaceutical company that enhances patient health and extends independence.
Industries
Nr. of Employees
large (251-1000)
Cytokinetics, Inc
South San Francisco, California, United States, North America
Products
Pipeline of investigational small-molecule sarcomere-targeted therapeutics
A portfolio of investigational small molecules designed to modulate sarcomere function for cardiovascular and neuromuscular indications; programs span discovery through late-stage clinical development.
Pipeline of investigational small-molecule sarcomere-targeted therapeutics
A portfolio of investigational small molecules designed to modulate sarcomere function for cardiovascular and neuromuscular indications; programs span discovery through late-stage clinical development.
Services
Postdoctoral Fellows Program
Two-year funded research fellowships providing independent research projects, mentorship, and training in muscle biology and drug discovery.
Internship Program
Seasonal internship placements offering project work, networking, and industry exposure for students and recent graduates.
Managed access and open-label extension management
Administration of limited managed access programs and open-label extension studies to provide investigational therapy access and collect long-term safety/efficacy data.
Postdoctoral Fellows Program
Two-year funded research fellowships providing independent research projects, mentorship, and training in muscle biology and drug discovery.
Internship Program
Seasonal internship placements offering project work, networking, and industry exposure for students and recent graduates.
Managed access and open-label extension management
Administration of limited managed access programs and open-label extension studies to provide investigational therapy access and collect long-term safety/efficacy data.
Expertise Areas
- Muscle biology and sarcomere pharmacology
- Preclinical translational pharmacology
- Medicinal chemistry and lead optimization
- ADME/DMPK and translational science
Key Technologies
- Small-molecule drug discovery
- In vivo disease models
- Next-generation sequencing (NGS)
- Proteomics